IRIS
CAVESTRO, Giulia Martina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.340
AS - Asia 5.477
EU - Europa 4.139
SA - Sud America 717
AF - Africa 305
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 5
Totale 16.991
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.139
SG - Singapore 2.201
CN - Cina 1.498
VN - Vietnam 773
IT - Italia 735
SE - Svezia 650
IE - Irlanda 622
BR - Brasile 542
UA - Ucraina 531
FI - Finlandia 435
DE - Germania 416
HK - Hong Kong 367
TR - Turchia 218
ZA - Sudafrica 210
FR - Francia 182
NL - Olanda 173
GB - Regno Unito 136
CA - Canada 131
BD - Bangladesh 122
RU - Federazione Russa 95
AR - Argentina 74
CI - Costa d'Avorio 54
IN - India 50
MX - Messico 38
IQ - Iraq 33
JP - Giappone 27
BE - Belgio 26
PL - Polonia 22
EC - Ecuador 21
PH - Filippine 20
AT - Austria 19
LT - Lituania 19
CO - Colombia 17
ES - Italia 17
PK - Pakistan 17
UZ - Uzbekistan 17
PE - Perù 14
ID - Indonesia 13
IR - Iran 13
PY - Paraguay 13
TH - Thailandia 13
RO - Romania 12
TW - Taiwan 12
CL - Cile 11
AZ - Azerbaigian 10
VE - Venezuela 10
SA - Arabia Saudita 9
CZ - Repubblica Ceca 8
KE - Kenya 8
KR - Corea 8
MA - Marocco 8
TN - Tunisia 8
BO - Bolivia 7
EG - Egitto 7
EU - Europa 7
UY - Uruguay 7
CR - Costa Rica 6
JO - Giordania 6
PA - Panama 6
GE - Georgia 5
GT - Guatemala 5
IL - Israele 5
PT - Portogallo 5
AE - Emirati Arabi Uniti 4
HN - Honduras 4
HU - Ungheria 4
LB - Libano 4
MD - Moldavia 4
MY - Malesia 4
NP - Nepal 4
RS - Serbia 4
AL - Albania 3
AU - Australia 3
BG - Bulgaria 3
BN - Brunei Darussalam 3
NO - Norvegia 3
QA - Qatar 3
AM - Armenia 2
CG - Congo 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GR - Grecia 2
JM - Giamaica 2
KG - Kirghizistan 2
KH - Cambogia 2
LK - Sri Lanka 2
LV - Lettonia 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
TJ - Tagikistan 2
TT - Trinidad e Tobago 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BS - Bahamas 1
BY - Bielorussia 1
CH - Svizzera 1
EE - Estonia 1
ET - Etiopia 1
GI - Gibilterra 1
Totale 16.971
Salva come PNG Salva come JPEG
Città #
Singapore 1.020
Chandler 859
Ashburn 629
Dublin 619
Jacksonville 539
Santa Clara 506
San Jose 417
Dearborn 401
Hong Kong 350
Beijing 282
Ho Chi Minh City 260
Boardman 259
Nanjing 252
Johannesburg 200
Izmir 174
Dallas 161
Hanoi 161
Princeton 154
San Mateo 147
Genoa 139
Lauterbourg 137
Ann Arbor 122
Shanghai 114
Tito 114
New York 111
Munich 106
Los Angeles 97
Toronto 89
Shenyang 84
Wilmington 81
Nardò 73
Helsinki 70
Moscow 68
Nanchang 60
Taranto 58
Abidjan 54
São Paulo 54
Hebei 53
Kunming 47
Tianjin 46
Changsha 42
Buffalo 40
Hefei 40
Jiaxing 39
Jinan 39
Da Nang 34
Turku 30
Norwalk 29
Parma 29
Frankfurt am Main 28
Kocaeli 26
Woodbridge 26
Brussels 25
Bari 22
Guangzhou 22
Houston 21
Haiphong 20
Des Moines 19
Hangzhou 19
Tokyo 19
Zhengzhou 19
Columbus 18
Denver 18
Council Bluffs 17
Hải Dương 17
Montreal 17
Warsaw 17
Chicago 16
London 16
Orem 16
Pune 16
Stockholm 16
Seattle 15
Tashkent 15
Brindisi 14
Rio de Janeiro 14
Tricase 14
Grafing 13
Phoenix 13
Rome 13
Belo Horizonte 12
Boston 12
Brooklyn 12
Cambridge 12
Ningbo 12
Baghdad 11
Brasília 11
Bremen 11
Can Tho 11
Cascina 11
Lima 11
San Gregorio di Catania 11
Atlanta 10
Nuremberg 10
Porto Alegre 10
Quito 10
San Francisco 10
Surbo 10
Auburn Hills 9
Baku 9
Totale 10.265
Salva come PNG Salva come JPEG
Nome #
Associations of spink-1 (N345) and PRSS-1 (N29I AND R122H) gene mutations and chronic pancreatitis in Italy 487
5 OP Keratin 8 gene mutation in patients with chronic pancreatitis 420
A curcumin-based 1-week triple therapy for eradication of Helicobacter pylori infection: something to learn from failure? 185
W1079 Curcumin Vs Domperidon in Functional Dyspepsia: Better the Prokinetic or An Agonist of Vanilloid Receptor? 169
710 Gastrin-17 (G-17): A Serological Bio-Marker for Diagnosis of Gastro-Esophageal Reflux Disease (GERD) 164
Quality of life in uncomplicated diverticular disease: Is it another good reason for the treatment? 161
Association of HLA-DRB1 *0401 Allele with chronic pancreatitis 159
Autonomic balance in inflammatory bowel diseases, irritable bowel syndrome and gastroesophageal reflux disease 158
Natural course of functional dyspepsia after after helicobacter pylori eradication a 7-year survey 155
Association of keratin 8 gene mutation with chronic pancreatitis 153
7 P Frequency of CFTR gene mutations in consecutive patients suffering from chronic pancreatitis 153
Gastro panel® for detection of atrophic gastritis: The “Parma model” 152
Clinical Trends and Burden of Death in Gastric Cancer: A Six Years Survey 152
P.08.9: The Early Diagnosis of Gastric Cancer: A Six Years Survey Based on 584 Surgical Specimen in Parma Area 150
Serum pepsinogen II for early assessment of success of H. pylori eradication 148
42 OP Potential use of lactoferrin in a 7 days triple therapy for helicobacter pylori eradication: A pilot study 147
S1921 “GastroPanel Test” in the Clinical Outcome of GERD 147
S1808 Connections Between Genetics and Clinical Data: Role of MCP-1, CFTR and SPINK-1 in the Clinical Setting of Acute, Acute Recurrent and Chronic Pancreatitis 147
T1082 Eradication Rate of Helicobacter pylori in Immigrant Patients Compared to Italian Patients: Results of a Clinical Trial 146
Accuracy of “serological gastric biopsy” in a cohort of dyspeptic patients 145
Gastrin-17 (G-17) as a sensitive serological bio-marker for diagnosis of gastro-esophageal reflux disease (GERD) independently of H. pylori status 144
Bovine lactoferrin as a rescure treatment for Helicobacter pylori infection: results of a multicenter study 140
T1651 The Natural History of Gastric Ulcer: A Twenty-Four Years Clinical-Endoscopical Follow-Up 140
P.1.193: MESALAMINE FOR THE MANAGEMENT OF PATIENTS WITH UNCOMPLICATED DIVERTICULAR DISEASE (SUDD): A 24 MONTHS PROSPECTIVE FOLLOW-UP STUDY 138
P.29 USEFULNESS OF NON INVASIVE TEST (GASTROPANEL) FOR SCREENING OF ATROPHIC GASTRITIS IN PATIENTS WITH AUTOIMMUNE THYROID DISEASE 138
P.154 CONNECTIONS BETWEEN GENETICS AND CLINICAL DATA: ROLE OF MCP-1, CFTR, AND SPINK-1 IN THE SETTING OF ACUTE, ACUTE RECURRENT, AND CHRONIC PANCREATITIS 137
Esophagitis: acute therapy with omeprazole (Single Dosage Versus BID) 137
OC1.09.3 USEFULNESS OF GASTROPANEL FOR SCREENING OF ATROPHIC GASTRITIS IN PATIENTS WITH AUTOIMMUNE THYROID DISEASES 136
Usefulness of Serum Pepsinogens to Identify Chronic Atrophic Gastritis 135
PA.7 CLINICAL VARIABILITY IN THE PRESENTATION OF THE GASTROESOPHAGEAL REFLUX DISEASE BEFORE THE HP ERA (STUDY FROM 1975 TO 1995) 134
Low alcohol and cigarette use is associated to the risk of developing chronic pancreatitis 134
M1260 Effect of Cyclically Long-Term Treatment With Mesalamine in Patients With Symptomatic Uncomplicated Diverticular Disease (SUDD): A 5 Years Follow-up Study 133
OC3.07.1 CURCUMIN VS DOMPERIDON IN FUNCTIONAL DYSPEPSIA: BETTER THE PROKINETIC OR AN AGONIST OF VANILLOID RECEPTOR? 133
Pepsinogen I, II, Ratio, and G-17 in Patients With Esophagitis and Patients With Extra-Esophageal Manifestations of GERD 133
Associations of Spink-1 (N34S) and PRSS-1 (N29I and R122H) gene mutations and chronic pancreatitis in Italy 132
PA.6 GASTRIN-17 (G-17): A SEROLOGICAL BIO-MARKER FOR DIAGNOSIS OF GASTRO-ESOPHAGEAL REFLUX DISEASE (GERD) 132
Bovine lactoferrin for Helicobacter pylori eradication: an open, randomized, multicentre study. 130
Rabepmzole in the treatment of non-responders GERD patients: a prospective six-month study 130
M1262 Baseline Symptoms in Patients With Symptomatic Uncomplicated Diverticular Disease (SUDD) 130
M1141 Diagnostic Accuracy of Serum Pepsinogens and Gastrin to Follow-up Helicobacter pylori Infection: A Pilot Study 129
Gastroesophageal reflux disease in celiac patients: Preliminary results in 35 consecutive patients 129
Usefulness of a serological panel test in the assessment of gastritis in symptomatic children 127
A new marker for monitoring alcohol abuse? A pilot study on heavy drinkers 127
LONG-TERM TREATMENT WITH MESALAMINE IN DIVERTICULAR DISEASE: A FIVE YEARS FOLLOW-UP STUDY 126
Lactoferrin in a 1-week triple therapy for eradication of H. pylori 125
Italian consensus guideline for chronic pancreatitis. 123
A prospective therapeutical one-year study with pantoprazole for patients with oropharingeal picture of GERD 123
A degradation-sensitive anionic trypsinogen (PRSS2) variant protects against chronic pancreatitis 122
A new curcumin-based one week therapy for eradication of H. pylori infection 120
“GASTROPANEL TEST” IN THE CLINICAL OUTCOME OF GERD 118
P.1.292: SYMPTOMATOLOGICAL PATTERN IN PATIENTS WITH SYMPTOMATIC UNCOMPLICATED DIVERTICULAR DISEASE (SUDD), IRRITABLE BOWEL SYNDROME-DIARRHOEA (IBS-D), AND IBS-D PLUS SUDD 118
PANCREATIC PSEUDOCYSTS FOLLOWING ACUTE PANCREATITIS: RISK FACTORS INFLUENCING THERAPEUTIC OUTCOMES 117
Serum pepsinogen II and gastrin-17 as markers of NSAIDs gastropathy 117
PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS 117
Disappearance of gallbladder wall lesions after treatment with ursodeozycolic acid 116
Chronic atrophic gastritis (GAC) and Helicobacter pylori infection eradication: a 3 years follow-up 114
P.10 “GASTROPANEL TEST” IN THE CLINICAL OUTCOME OF GERD: PROSPECTIVE SIX MONTHS CLINICAL STUDY 114
Topography of gastric damage in H.pylori infection: evaluation by serum pepsinogens levels 113
Colorectal cancer incidences in Lynch syndrome: a comparison of results from the prospective lynch syndrome database and the international mismatch repair consortium 111
Are there useful biomarkers for gastric cancer? 111
Hypercalcemia due to ectopic secretion of parathyriod related protein from pancreatic carcinoma: a case report 111
Clinical and radiological outcome of patients suffering from chronic pancreatitis associated with gene mutations. 111
DO PREBIOTICS RELIEVE CONSTIPATION-PREDOMINANT IRRITABLE BOWEL SYNDROME (IBS-C) SYMPTOMS? A RANDOMIZED SINGLE BLINDED STUDY 110
Recovery of gastric function after H. pylori eradication in subjects with body atrophic gastritis: a prospective four years study 109
Study design biases in pancreatic inflammatory diseases. 108
Meta-analysis of the impact of SPINK1 p.N34S gene variation in Caucasic patients with chronic pancreatitis. An update 108
CORRELATION BETWEEN LACTOSE H2-BREATH TEST AND CLINICAL DATA: IS IT POSSIBLE TO SELECT PATIENTS WHO NEED LACTOSE BREATH TEST? 107
Lactoferrin: mechanism of action, clinical significance and therapeutic 106
Quality of life in patients with chronic pancreatitis 105
Usefullness of gastropanel in different topography of H. pylori related chronic gastritis 105
Assessment of H. pylori-related chronic gastritis by means of serum pepsinogens and oral sucrose 104
Prevalence of H. pylori CagA+ve in suburban area with high incidence of gastric cancer 103
Efficacy of mesalazine in the treatment of symptomatic diverticular disease 103
Imaging of a small bowel cavernous hemangioma: report of a case with emphasis on the use of computed tomography and enteroclysis. 102
P.1.325: USEFULNESS OF SERUM PEPSINOGENS TO IDENTIFY CHRONIC ATROP H IC GASTRITIS 101
Gastroprotective effects of Amtolmetin Guacyl: a new non steroidal antiinflammatory drug that activates inducible gastric niytric oxide synthase 100
“The yellow stomach“: clinical relevance in endoscopical series 99
Prevention of complications and symptomatic recurrences in diverticular disease with mesalazine: a 12-month follow-up. 99
Nonteroidal drug-related gastroduodenal damage in the elderly 98
THE SIZE OF PANCREATIC PSEUDOCYST DOES NOT INFLUENCE THE OUTCOME OF INVASIVE TREATMENTS 97
Recovery of gastric function after Helicobacter pylori eradication in subjects with body atrophic gastritis: prospective 4-year study 96
Therapy of NERD: single Vs double rabeprazole dosage 96
Macrohematuria caused by a fall in prothrombin activity as a clinical presentation of celiac disease. (I.F. 1.357) 96
TAP genes, coding for the transporters associated with antigen processing, contribute to the genetic predisposition to primary sclerosing cholangitis (PSC) 96
Influence of antisecretory treatment with proton pump inhibitors on serum pepsinogen I levels 95
Rabeprazole for the treatment of oropharingeal picture of GERD: a six-month prospective study 95
Hyperbilirubinemia: does it matter? 95
Novel association of HLA-haplotypes with primary sclerosing cholangitis (PSC) in a southern European population 95
Ursodeoxycholic acid Vs cisapride in the treatment of duodenogastric reflux 95
Lactoferrin in a one week triple therapy for eradication of H. Pylori 94
Diagnosis of H. pylori gastritis patterns by means of gastropanel 94
Relationship between direct and indirect methods for diagnosis of H.pylori infection 94
‘Serological Biopsy’ in first degree relatives of patients with gastric cancer, affected by Helicobacter pylori 94
Serum pepsinogen II as a biomarker in management of H. pylori infection 94
Gastropanel as screening of gastric atrophy in primary care 93
Clinical usefulness of Gastropanel (SPGI, SPGII, GASTRIN-17, HP SPECIFIC IgG) in the assessment of HP infection 93
Clinical usefulness of serum pepsinogen II in the assessment of H. pylori infection 93
HLA-DRB1*04 Allele contribute to the genetic susceptibility of chronic pancreatitis 93
Early epigastric pain after PPI administration: exacerbation of Helicobacter pyolori corpus gastritis? 93
Serum pepsinogen II and Gastrin-17 (G-17) as markers of NSAIDS gastropathy 92
Totale 12.753
Salva come PNG Salva come JPEG
Categoria #
all - tutte 59.041
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.041
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20218 0 0 0 0 0 0 0 0 0 0 0 8
2021/2022777 14 15 10 36 43 17 80 108 32 87 92 243
2022/20232.618 294 253 169 234 238 325 7 188 797 9 81 23
2023/2024784 53 84 24 22 56 217 40 61 18 48 77 84
2024/20253.030 83 187 214 148 364 356 36 142 452 286 219 543
2025/20266.014 515 523 519 542 853 442 640 168 858 519 289 146
Totale 17.051